The role of glucagon secretion in obesity development is currently uncertain, and although its actions on food intake and liver fat may be pharmacologically relevant, its further metabolic actions may be difficult to harness. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.